- Balderton News
- 22 October, 2024
Related content
- Balderton News
- 11 October, 2024
Thor Mitchell joins Balderton as Executive In Residence
- Portfolio News
- 25 September, 2024
Convergence raises $12M to build personal AI agents with long-term memory
- Portfolio News
- 12 September, 2024
DELLI raises $6M to accelerate its independent food and drink platform
- Balderton News
- 10 September, 2024
Reflecting on Balderton’s first team Impact Day
- Portfolio News
- 28 August, 2024
Attio raises $33 million in funding
- Balderton News
- 12 August, 2024
Early Stage Fund IX and Growth Fund II: Our commitment to European founders
- Balderton News
- 12 August, 2024
Balderton announces $1.3B in new funds to back Europe’s top entrepreneurs as they build world-changing businesses
- Portfolio News
- 01 August, 2024
Healx announces $47M Series C and FDA clearance of Phase 2 IND for Neurofibromatosis Type 1 Trial
- Portfolio News
- 31 July, 2024